Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (91-100 of 260) with videos related to

Pageof 26
Sort By:
Cancer Communications|January 1, 1990
The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cellsE J Katz, P A Andrews, S B Howell
European Journal of Cancer & Clinical Oncology|April 1, 1989
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cellsP A Andrews, M P Murphy, S B Howell
Molecular Pharmacology|August 27, 1999
Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatinE D Scheeff, J M Briggs, S B Howell
Medical and Pediatric Oncology|January 1, 1982
Modulation of the cellular pharmacology and clinical toxicity of 1-beta-D-arabinofuranosylcytosineS B Howell, J A Streifel, C E Pfeifle
Progress in Clinical and Biological Research|January 1, 1986
Cellular resistance to platinating agents in ovarian carcinomaP A Andrews, M P Murphy, S B Howell
International Journal of Cancer|July 30, 1991
Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B Howell
Cancer|July 1, 1986
Cisplatin administered by the intracavitary route as treatment for malignant mesotheliomaM Markman, S Cleary, C Pfeifle, et al.
Clinical Pharmacology and Therapeutics|November 1, 1979
Effect of probenecid on cerebrospinal fluid methotrexate kineticsS B Howell, R A Olshen, J A Rice
Cancer Research|December 1, 1985
Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletionP A Andrews, M P Murphy, S B Howell
Journal of the National Cancer Institute|January 1, 1981
Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cellsB C Chu, C C Fan, S B Howell
Pageof 26

Showing results (91-100 of 260) with videos related to

Sort By:
Pageof 26
Cancer Communications|January 1, 1990
The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cellsE J Katz, P A Andrews, S B Howell
European Journal of Cancer & Clinical Oncology|April 1, 1989
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cellsP A Andrews, M P Murphy, S B Howell
Molecular Pharmacology|August 27, 1999
Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatinE D Scheeff, J M Briggs, S B Howell
Medical and Pediatric Oncology|January 1, 1982
Modulation of the cellular pharmacology and clinical toxicity of 1-beta-D-arabinofuranosylcytosineS B Howell, J A Streifel, C E Pfeifle
Progress in Clinical and Biological Research|January 1, 1986
Cellular resistance to platinating agents in ovarian carcinomaP A Andrews, M P Murphy, S B Howell
International Journal of Cancer|July 30, 1991
Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B Howell
Cancer|July 1, 1986
Cisplatin administered by the intracavitary route as treatment for malignant mesotheliomaM Markman, S Cleary, C Pfeifle, et al.
Clinical Pharmacology and Therapeutics|November 1, 1979
Effect of probenecid on cerebrospinal fluid methotrexate kineticsS B Howell, R A Olshen, J A Rice
Cancer Research|December 1, 1985
Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletionP A Andrews, M P Murphy, S B Howell
Journal of the National Cancer Institute|January 1, 1981
Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cellsB C Chu, C C Fan, S B Howell
Pageof 26